Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer 11/06/2018 INTERVENTIONAL not-comparable 2,895.75 0 Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer 11/07/2018 INTERVENTIONAL not-comparable 2,894.75 0 Peer Approaches to Lupus Self-management 11/07/2018 INTERVENTIONAL not-comparable 2,894.75 0 Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer 11/08/2018 INTERVENTIONAL not-comparable 2,893.75 0 Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients 11/09/2018 INTERVENTIONAL not-comparable 2,892.75 0 An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS 11/13/2018 INTERVENTIONAL not-comparable 2,888.75 0 The Role of Estrogen in the Neurobiology of Eating Disorders 11/14/2018 INTERVENTIONAL not-comparable 2,887.75 0 A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer 11/15/2018 INTERVENTIONAL not-comparable 2,886.75 0 Cardiovascular Disease Risk in Women With Endometriosis 11/19/2018 INTERVENTIONAL not-comparable 2,882.75 0 3D Animation and Models to Aid Management of Fetal CDH 11/23/2018 OBSERVATIONAL not-comparable 2,878.75 0 Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital 11/23/2018 INTERVENTIONAL not-comparable 2,878.75 0 Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance 11/28/2018 OBSERVATIONAL not-comparable 2,873.75 0 Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies 12/03/2018 OBSERVATIONAL not-comparable 2,868.75 0 AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model. 12/05/2018 INTERVENTIONAL not-comparable 2,866.75 0 Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making 12/05/2018 INTERVENTIONAL not-comparable 2,866.75 0 LAparoscopic Preventive PRErectal Mesh 12/05/2018 INTERVENTIONAL not-comparable 2,866.75 0 Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube 12/11/2018 INTERVENTIONAL not-comparable 2,860.75 0 Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 12/11/2018 INTERVENTIONAL not-comparable 2,860.75 0 Post Operative Cognitive Dysfunction After Breast Surgery 12/13/2018 OBSERVATIONAL not-comparable 2,858.75 0 Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise 12/14/2018 OBSERVATIONAL not-comparable 2,857.75 0 Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors 12/17/2018 INTERVENTIONAL not-comparable 2,854.75 0 Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer 12/24/2018 OBSERVATIONAL not-comparable 2,847.75 0 Vaginal Cuff Brachytherapy Fractionation Study 12/24/2018 INTERVENTIONAL not-comparable 2,847.75 0 Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule 12/24/2018 INTERVENTIONAL not-comparable 2,847.75 0 Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer 12/26/2018 INTERVENTIONAL not-comparable 2,845.75 0 One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer 12/27/2018 INTERVENTIONAL not-comparable 2,844.75 0 Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study 01/04/2019 INTERVENTIONAL not-comparable 2,836.75 0 Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization 01/07/2019 OBSERVATIONAL not-comparable 2,833.75 0 Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer 01/07/2019 INTERVENTIONAL not-comparable 2,833.75 0 Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer 01/08/2019 INTERVENTIONAL not-comparable 2,832.75 0 A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer 01/09/2019 OBSERVATIONAL not-comparable 2,831.75 0 Converting HR+ Breast Cancer Into an Individualized Vaccine 01/15/2019 INTERVENTIONAL not-comparable 2,825.75 0 Mechanisms of Pregnancy Vascular Adaptations 01/16/2019 OBSERVATIONAL not-comparable 2,824.75 0 Cognitive Training for Patients With Eating Disorders 01/17/2019 INTERVENTIONAL not-comparable 2,823.75 0 Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO 01/24/2019 INTERVENTIONAL not-comparable 2,816.75 0 Elevate! : An Elderly Breast Cancer Cohort Study 01/28/2019 OBSERVATIONAL not-comparable 2,812.75 0 Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible 01/28/2019 OBSERVATIONAL not-comparable 2,812.75 0 Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections 01/28/2019 INTERVENTIONAL not-comparable 2,812.75 0 Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer 01/29/2019 INTERVENTIONAL not-comparable 2,811.75 0 Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair 01/29/2019 INTERVENTIONAL not-comparable 2,811.75 0 Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease 01/30/2019 INTERVENTIONAL not-comparable 2,810.75 0 A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy 01/30/2019 INTERVENTIONAL not-comparable 2,810.75 0 Bioimpedance In Pregnancy and Labour: A Fluid Balance Concept Study. 01/31/2019 OBSERVATIONAL not-comparable 2,809.75 0 HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer 02/01/2019 INTERVENTIONAL not-comparable 2,808.75 0 Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II 02/04/2019 INTERVENTIONAL not-comparable 2,805.75 0 Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment 02/04/2019 INTERVENTIONAL not-comparable 2,805.75 0 Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting 02/05/2019 INTERVENTIONAL not-comparable 2,804.75 0 PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood 02/05/2019 INTERVENTIONAL not-comparable 2,804.75 0 Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer 02/06/2019 INTERVENTIONAL not-comparable 2,803.75 0 TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation 02/07/2019 INTERVENTIONAL not-comparable 2,802.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology